Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001680367-25-000034
Filing Date
2025-05-01
Accepted
2025-05-01 16:28:54
Documents
54
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sttk-20250331.htm   iXBRL 10-Q 627952
2 EX-31.1 sub-certxsection302xcfoxq1.htm EX-31.1 17189
3 EX-31.2 sub-certxsection302xceoxq1.htm EX-31.2 17222
4 EX-32.1 sub-certxsection906ofthesa.htm EX-32.1 9492
  Complete submission text file 0001680367-25-000034.txt   4348453

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20250331.xsd EX-101.SCH 26610
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20250331_cal.xml EX-101.CAL 35140
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20250331_def.xml EX-101.DEF 135798
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20250331_lab.xml EX-101.LAB 489783
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20250331_pre.xml EX-101.PRE 317457
56 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20250331_htm.xml XML 466938
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39593 | Film No.: 25903693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)